Skip to content
The Detroit

New drug poised to transform pancreatic cancer care after FDA approval

In todays Health Alert, the FDA has approved a new targeted drug for advanced pancreatic cancer. In a clinical trial, it helped patients live twice as long compared to those treated with standard chemotherapy. New drug poised to transform pancreatic cancer care after FDA approval This is big news...

Sources and story details